| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/25/2007 | US7273968 Combinations of genes for producing seed plants exhibiting modulated reproductive development |
| 09/25/2007 | US7273931 Plant promoter |
| 09/25/2007 | US7273930 Immunization of dairy cattle with GapC protein against Streptococcus infection |
| 09/25/2007 | US7273929 B1k chain of laminin and methods of use |
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273927 Mdm2 splice variants |
| 09/25/2007 | US7273926 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 09/25/2007 | US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses |
| 09/25/2007 | US7273923 Plant protein for use as tool in cintrolling gene expression plants |
| 09/25/2007 | US7273922 Semaphorin Z and gene encoding the same |
| 09/25/2007 | US7273921 Method for producing acylated peptides |
| 09/25/2007 | US7273920 Controlling protein levels in eucaryotic organisms |
| 09/25/2007 | US7273854 Recombinant adenovirus, adeno-associated virus or herpes virus (especially a replication defective virus) containing a nucleic acid of a specific sequence encoding an antisense RNA that inhibits expression of p53. |
| 09/25/2007 | US7273850 Administering to the cell all or part of a peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for inhibiting calcium uptake by a cancer cell |
| 09/25/2007 | US7273849 ProapolipoproteinA-I mutant and pharmaceutical composition comprising the same for prevention and treatment of atherosclerosis and hyperlipidemia |
| 09/25/2007 | US7273848 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 09/25/2007 | US7273847 Peptides with antioxidant and antimicrobial properties |
| 09/25/2007 | US7273846 Selective melanin-concentrating hormone type-1 receptor agonists |
| 09/25/2007 | US7273844 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 09/25/2007 | US7273843 Methods of treating allergy by administering interleukin-17 receptor |
| 09/25/2007 | US7273758 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 09/25/2007 | US7273754 Core 1 β3-galactosyltransferase specific molecular chaperones, nucleic acids, and methods of use thereof |
| 09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
| 09/25/2007 | US7273747 Cell having amplified signal transduction pathway responses and uses therefor |
| 09/25/2007 | US7273739 Claimed are specific enzymes having strand cleavage activity, 3' to 5' exonuclease activity, and polymerase activity that are combined with a heteroduplex polynucleotide to increased complementarity within the heteroduplex |
| 09/25/2007 | US7273728 Fermenting an appropriate microorganism using glucose as a carbon source and operating two chromatographic separation steps wherein ion exchange chromatography is followed by hydrophobic interaction chromatography, wherein the diphtheria toxin has a purity of at least 98%. |
| 09/25/2007 | US7273727 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
| 09/25/2007 | US7273726 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 09/25/2007 | US7273725 Human and mammalian stem cell-derived neuron survival factors |
| 09/25/2007 | US7273724 Also producing the polypeptide by DNA recombinant technology |
| 09/25/2007 | US7273722 Insertion of cleavage sites in non-critical regions of the toxins which are susceptible to protease activity in non-target tissues and single chain forms activated by proteases in the target; botulism and tetanus toxins; confine activity to target site; side effect reduction |
| 09/25/2007 | US7273721 Used in identification of microorganisms which can be used to produce fine chemicals, the modulation of fine chemical production in C. glutamicum or related bacteria, the typing or identification of C. glutamicum as transformation markers |
| 09/25/2007 | US7273710 Method for screening MCH receptor antagonist/agonist |
| 09/25/2007 | US7273709 Detection of sarcocystis neurona |
| 09/25/2007 | US7273708 Assays for preimplantation factor and preimplantation factor peptides |
| 09/25/2007 | US7273707 Comprises lymphotoxin beta receptor (LT BETA R) for diagnosis, prevention and treatment of cancer, inflammatory and autoimmune diseases |
| 09/25/2007 | US7273698 Defects in periaxin associated with myelinopathies |
| 09/25/2007 | US7273696 Kits for the detection of target sequences |
| 09/25/2007 | US7273695 HIV immunoassays using synthetic envelope polypeptides |
| 09/25/2007 | US7273617 Vaccines |
| 09/25/2007 | US7273616 Genetically engineered cell lines and systems for propagating Varicella zoster virus and methods of use thereof |
| 09/25/2007 | US7273614 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 09/25/2007 | US7273613 Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders |
| 09/25/2007 | US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/25/2007 | US7273611 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
| 09/25/2007 | CA2237338C Stable avidin composition and methods using same |
| 09/25/2007 | CA2192442C Complementary adenoviral vector systems and cell lines |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/25/2007 | CA2143898C A process for reactivating purified membrane proteins by freezing them |
| 09/25/2007 | CA2132868C Method of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells |
| 09/25/2007 | CA2128109C Improvements in or relating to malaria vaccine |
| 09/25/2007 | CA2112701C Proteins s polypeptides and uses thereof |
| 09/20/2007 | WO2007106894A2 Neutralizing agents for bacterial toxins |
| 09/20/2007 | WO2007106799A2 Multivalent clostridial toxins |
| 09/20/2007 | WO2007106472A2 Non-mccj25-related lariat-peptide inhibitors of bacterial rna polymerase |
| 09/20/2007 | WO2007106121A2 Design and construction of dimeric concanavalin a mutants |
| 09/20/2007 | WO2007106115A1 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 09/20/2007 | WO2007106078A2 Clarification of transgenic milk using depth filtration |
| 09/20/2007 | WO2007106056A1 Compositions and methods for treating t-cell mediated pathological conditions |
| 09/20/2007 | WO2007105734A1 Crustacean-derived protein having antifreeze activity |
| 09/20/2007 | WO2007105731A1 Protein having ice nucleating activity |
| 09/20/2007 | WO2007105461A2 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 09/20/2007 | WO2007105442A1 Therapeutic agent for food intake disorder or water intake disorder |
| 09/20/2007 | WO2007105350A2 Catalase gene and use thereof |
| 09/20/2007 | WO2007105022A1 Modulation of glutamine synthetase activity |
| 09/20/2007 | WO2007104979A1 Virus-like particles of rift valley fever virus |
| 09/20/2007 | WO2007104945A2 Proteins, nucleic acids and medicaments |
| 09/20/2007 | WO2007104934A2 Protein folding |
| 09/20/2007 | WO2007104932A2 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof |
| 09/20/2007 | WO2007104835A1 Use of a growth-stimulating protein |
| 09/20/2007 | WO2007104789A2 Amylin derivatives |
| 09/20/2007 | WO2007104782A1 Recombinant newcastle disease virus expressing h5 hemagglutinin of avian influenza virus |
| 09/20/2007 | WO2007104768A2 Di-polymer protein conjugates and processes for their preparation |
| 09/20/2007 | WO2007104739A1 Promoter mutations that increase amyloid precursor protein expression |
| 09/20/2007 | WO2007104738A2 Acylated single chain insulin |
| 09/20/2007 | WO2007104737A1 Acylated single chain insulin |
| 09/20/2007 | WO2007104736A2 Acylated single chain insulin |
| 09/20/2007 | WO2007104734A1 Acylated single chain insulin |
| 09/20/2007 | WO2007104567A2 Pegylated mutated clostridium botulinum toxin |
| 09/20/2007 | WO2007104556A1 Pat1-type protein assay |
| 09/20/2007 | WO2007104529A2 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 09/20/2007 | WO2007104523A1 Use of iex-1 for the treatment of glioma tumors |
| 09/20/2007 | WO2007104263A1 An enhancin of hepatitis b virus vaccine and its gene |
| 09/20/2007 | WO2007104181A1 Uses of dkk-1 protein in diagnosis of cancers |
| 09/20/2007 | WO2007084531A3 A novel binding site for retigabine on kcnq5 |
| 09/20/2007 | WO2007079457A3 Materials and methods for immunizing against fiv infection |
| 09/20/2007 | WO2007071994A3 Viral vectors |
| 09/20/2007 | WO2007070996A3 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis |
| 09/20/2007 | WO2007058823A3 Anti-egfr antibodies |
| 09/20/2007 | WO2007058527A3 Inducible expression systems |
| 09/20/2007 | WO2007057018A3 Glucoamylase variants |
| 09/20/2007 | WO2007051218A3 Method using human or mouse isg12 for the development and production of medicaments and single nucleotide polymorphism in the isg12 gene for diagnostic purposes |
| 09/20/2007 | WO2007050661A3 C-reactive protein and its use to treat systemic lupus erythematosus and related conditions |
| 09/20/2007 | WO2007050390A3 Botulinum neurotoxin a receptor and the use thereof |
| 09/20/2007 | WO2007041513A3 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 09/20/2007 | WO2007039728A3 AVß6 PEPTIDE LIGANDS AND THEIR USES |
| 09/20/2007 | WO2007019860A3 Gdnf derived peptides |
| 09/20/2007 | WO2007017892A3 Novel compounds as glp-i agonists |